Karolina Akinosoglou Selected Research

Dexamethasone (Maxidex)

11/2021	Dexamethasone in COVID-19: Should we consider a "golden hour" practice?
10/2021	Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karolina Akinosoglou Research Topics

Disease

15	COVID-19 01/2022 - 01/2020
9	Sepsis (Septicemia) 01/2022 - 02/2014
8	Infections 01/2022 - 11/2012
5	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
3	Critical Illness (Critically Ill) 01/2022 - 02/2014
3	Pneumonia (Pneumonitis) 11/2020 - 02/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Bacteremia 01/2022 - 01/2021
2	Disease Progression 01/2022 - 10/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 01/2021
2	Wounds and Injuries (Trauma) 01/2021 - 03/2009
2	Stroke (Strokes) 12/2019 - 01/2018
2	Hemorrhage 10/2015 - 02/2014
1	Coinfection 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 06/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Surgical Wound Infection 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Macrophage Activation Syndrome 10/2020
1	Inflammation (Inflammations) 10/2020
1	Human Influenza (Influenza) 10/2020
1	Lymphopenia (Lymphocytopenia) 10/2020
1	Endotoxemia 01/2020
1	Neoplasms (Cancer) 12/2019
1	Peptic Ulcer (Peptic Ulcers) 12/2019
1	Skin Ulcer 12/2019
1	Atrial Fibrillation 12/2019
1	Peripheral Arterial Disease 01/2018
1	Fever (Fevers) 01/2017
1	Meningitis 11/2016
1	Pericarditis 11/2016
1	Abdominal Pain (Pain, Abdominal) 11/2016
1	Thalassemia 02/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2016
1	Atherosclerosis 02/2016
1	Atherosclerotic Plaque (Atheroma) 02/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	ST Elevation Myocardial Infarction 10/2015
1	Pancreatitis 11/2014
1	Acute Lung Injury 02/2014
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2014
1	Cushing Syndrome 01/2014
1	Hypokalemia 01/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2014
1	Heart Failure 09/2012
1	Persistent Infection 09/2012

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2012
5	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2020
4	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 01/2021
3	tocilizumab (atlizumab)FDA Link 01/2022 - 11/2020
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 10/2020
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2021 - 01/2020
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 10/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 10/2021
2	PlasminogenIBA 10/2021 - 10/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 10/2020
2	CytokinesIBA 10/2020 - 01/2020
2	Clopidogrel (Plavix)FDA Link 01/2018 - 10/2015
1	Tinzaparin (Innohep)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	RNA (Ribonucleic Acid)IBA 09/2021
1	Ketamine FDA LinkGeneric 07/2021
1	QuinolonesIBA 06/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	SteroidsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	HLA-DR Antigens (HLA-DR)IBA 10/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	EndotoxinsIBA 01/2020
1	ChemokinesIBA 01/2020
1	FluoroquinolonesIBA 12/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	AntipyreticsIBA 01/2017
1	InterleukinsIBA 01/2017
1	CalciumIBA 02/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	TicagrelorIBA 10/2015
1	CoagulantsIBA 02/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2014

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2012
1	Immunotherapy 01/2022
1	Postoperative Care 01/2022
1	Length of Stay 01/2022
1	Long-Term Care 12/2019
1	Adjuvant Chemotherapy 01/2016